CXR Biosciences is pleased to announce the appointment of Dr Mark Graham as a Pharmaceutical Investigative & Discovery Toxicology Consultant.
CXR offers tailored preclinical services in the areas of investigative & mechanistic toxicology, exploratory & discovery toxicology and PK & metabolism. Our customers include leading pharmaceutical, biotechnology, agrochemical, chemical and consumer product companies. The appointment of Mark brings extensive project-based toxicology, problem solving and regulatory expertise to CXR’s pharmaceutical practice. Prior to working with CXR, Mark has had 28 years of pharmaceutical toxicology experience, including 14 years at AstraZeneca, where he was most recently Senior Principal Scientist and Global Discipline Leader for Discovery Toxicology.
Mark has a track record of identifying mechanistic explanations in order to facilitate translational assessment of risk for humans. He has successfully applied this approach at all stages of drug discovery and development – from target identification to product registration. As well as his industrial experience, Mark has remained active in toxicological research by collaborating with several Universities, resulting in many peer reviewed scientific publications. He is a Fellow of the British Toxicology Society and a Member of the Committee On Toxicity (COT) which provides expert advice on chemical toxicity to the UK Government. Mark is also a member of the editorial board of the journal Xenobiotica.
Founded in 2001, CXR Biosciences® uses its collaborative approach and toxicological expertise to help customers of all sizes solve issues relating to the safety of compounds or selection of research candidates. CXR Biosciences® offers tailored preclinical services in the areas of investigative & mechanistic toxicology, exploratory & discovery toxicology and PK & metabolism. Our customers include leading pharmaceutical, agrochemical, chemical, consumer product and biotechnology companies. CXR Biosciences® is located in Dundee, Scotland, United Kingdom.